F · Healthcare

Monopar Therapeutics Inc. (1IY0)

Biotechnology

Monopar Therapeutics Inc. (1IY0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1IY0

P/E ratio

25.00

Monopar Therapeutics Inc. (1IY0) — FAQ

What is 1IY0's P/E ratio?

The price-to-earnings (P/E) ratio for Monopar Therapeutics Inc. (1IY0) is 25.00 (data as of 2026-05-24).

Does Monopar Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Monopar Therapeutics Inc. (1IY0). Check the MyAverix Finance app for the latest dividend data.

What sector is Monopar Therapeutics Inc. in?

Monopar Therapeutics Inc. (1IY0) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 1IY0 listed on?

1IY0 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)